Provided by Tiger Fintech (Singapore) Pte. Ltd.

Haemonetics

57.17
+0.28000.49%
Post-market: 57.170.00000.00%17:23 EDT
Volume:555.61K
Turnover:31.94M
Market Cap:2.87B
PE:22.52
High:58.46
Open:56.72
Low:56.64
Close:56.89
Loading ...

BD, Teleflex, Insulet, UFP Technologies, and Haemonetics Shares Are Falling, What You Need To Know

StockStory
·
11 Apr

Medical Devices & Supplies - Specialty Stocks Q3 Recap: Benchmarking STAAR Surgical (NASDAQ:STAA)

StockStory
·
08 Apr

Pharvaris Reports 2024 Financial Results and Advances HAE Treatment Studies

TIPRANKS
·
07 Apr

Pharvaris Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

GlobeNewswire
·
07 Apr

3 Stocks That May Be Trading Below Their Estimated Value In April 2025

Simply Wall St.
·
03 Apr

3 Reasons to Avoid HAE and 1 Stock to Buy Instead

StockStory
·
02 Apr

Is Intellia Therapeutics, Inc. (NTLA) the Best Gene-Editing Stock to Buy?

Insider Monkey
·
02 Apr

Pharvaris Announces Orphan Designation Granted to Deucrictibant by the European Commission

GlobeNewswire
·
01 Apr

Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2025 Results: May 8, 2025

PR Newswire
·
01 Apr

3 Promising Value Stocks Estimated To Be 13.1% To 46.3% Below Intrinsic Value

Simply Wall St.
·
01 Apr

Driven Brands Holdings Among 3 Stocks Priced Below Estimated Fair Value

Simply Wall St.
·
31 Mar

March 2025 Value Equities That Could Be Trading Below Estimated Worth

Simply Wall St.
·
26 Mar

KalVista Pharmaceuticals Announces Early Completion of Enrollment in KONFIDENT-KID Pediatric HAE Trial

Business Wire
·
25 Mar

3 Stocks Estimated To Be Trading At A Discount Of 25.2% To 28.2%

Simply Wall St.
·
25 Mar

Is Haemonetics (NYSE:HAE) Using Too Much Debt?

Simply Wall St.
·
18 Mar

Needham Trims Price Target on Haemonetics to $104 From $108, Keeps Buy Rating

MT Newswires Live
·
18 Mar

Haemonetics Is Maintained at Buy by Needham

Dow Jones
·
18 Mar

CSL is approaching a 5-year low. Is this a buying opportunity?

MotleyFool
·
18 Mar

IONS/AZN Get FDA Nod for Amyloidosis Drug, Wainzua in Europe

Zacks
·
11 Mar

Press Release: Astria Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate Update

Dow Jones
·
11 Mar